##  [Successful IND Submission in 4 Weeks with 70% Compliance Cost Savings](/index%2Ephp/case-studies/successful-ind-submission-in-4-weeks-with-70-compliance-cost-savings) 

- [Medicinal Products](/index%2Ephp/case-studies-main-categories/medicinal-products)
- [Publishing and Submission](/index%2Ephp/case-studies-main-categories/publishing-and-submission)





[TGA](/index%2Ephp/case-studies-heath-authority/tga)

[US FDA](/index%2Ephp/case-studies-heath-authority/us-fda)

 

 ![Successful IND Submission in 4 Weeks with 70% Compliance Cost Savings]()

A global top 20, Pharma company, involved in developing a set of diagnostic and monitoring tools for Celiac disease, approached Freyr for Investigational New Drug (IND) submissions. Apart from criticality of IND submissions, clients’ strategy for trials in two more regions and requirements of **eCTD conversions** made the project more challenging.

Read this case study to get insights on how Freyr successfully completed compliant IND submissions in just 4 weeks and met timelines for Phase 1 trials.



Fill the form below to download the Case Study

 You must have JavaScript enabled to use this form.

  

  

  

 How did you hear about us?Search EngineE-mail CampaignGoogle AdsSocial MediaLink from another websiteColleague’s RecommendationNewsletterPrinted BrochureOther 

  

 

 

     I have read the [privacy policy](https://www.freyrsolutions.com/privacy-policy) 



 

 Submitted Page URL  

 Website URL  

 Content Type  

 Form Name